Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries

Skin is the forestage for a series of many-sided functions of tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine with staggering versatility and sizable implications for tissue homeostasis, immune responses, angiogenesis, apoptosis, local and systemic inflammation. An aberrant TNF-alpha-mediated crosstalk has been linked to the pathogenesis of acute and chronic skin inflammatory diseases, and indeed, TNF-alpha dysregulation can contribute to the development and progression of psoriasis, vitiligo, local damage following exposition to ultraviolet light radiations, cutaneous lupus erythematosus, and acne vulgaris. Therapies that target TNF-alpha are conspicuously used in the treatment of different skin disorders, aiming to modulate the in vivo immune functions triggered by many cutaneous cells, including keratinocytes, mast cells, or Langerhans cells, and reduce inflammation taking place within the skin. Herein, we focus on the key relationships between TNF-alpha and distinct skin non-neoplastic inflammatory or physiologic conditions, showing that a natural induction of TNF-alpha may have a protective significance but that TNF-alpha overproduction may be harmful or even lethal. Many questions remain unraveled in the therapeutic practice, and caution should be exercised due to eventual backlashes exerted by TNF-alpha in maintaining skin health or in provoking skin disease.